Codeletion of CDKN2 and MTAP genes in a subset of non-hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma

Genes Chromosomes and Cancer

Volumn 22, Issue 1, 1998, Pages 72-78

  Dreyling, Martin H ^a   Roulston, Diane ^a   Bohlander, Stefan K ^a   Vardiman, James ^a   Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; LARGE CELL LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, LOW-GRADE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PURINE-NUCLEOSIDE PHOSPHORYLASE;

EID: 0031978858     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199805)22:1<72::AID-GCC10>3.0.CO;2-K     Document Type: Article

References (40)

1. Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA (1983) Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1:11-16.
2. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella K, Fruchart C, Duvan C, Monconduit M, Tilly H (1994) LAZ23 rearrangement in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype and clinical outcome in 217 patients. Blood 83:2423-2426.
3. Bohlander SK, Espinosa R 3d, Fernald AA, Rowley JD, Le Beau MMO, Diaz M (1994) Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenet Cell Genet 65:108-110.
4. Cairns P, Polascik J, Eby Y, Tokinok K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidvarsky D (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 11:210-212.
5. Chaganti SR, Gaidano G, Louie DC, Dalla-Favera R, Chaganti RSK (1995) Diffuse large-cell lymphomas exhibit frequent deletions in 9p21-22 and 9q31-34 regions. Genes Chromosomes Cancer 12: 32-36.
6. Cullen MH, Lister TA, Brearley RL, Shand WS, Stansfeld AG (1979) Histologic transformation of non-Hodgkin's lymphoma. A prospective study. Cancer 44:645-651.
7. Dreyling MH, Bohlander SK, Le Beau MM, Olopade OI (1995a) Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 86:1931-1938.
8. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI (1995b) Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase in situ hybridization. Cancer Res 55:984-988.
9. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley JD, Drabkin H (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript AML1/ETO, with similarity to drosophila segmentation gene, runt. Blood 80:1825-1831.
10. Fizzotti M, Cimino G, Pisegna S, Alimena CT, Quartarone C, Mandelli F, Pelicci PG, Lo Coco F (1995) Detection of homozygous deletions of the cyclin-dependent kinase-4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85:2685-2690.
11. Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R (1994) Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: Association with diffuse large-cell subtype. Blood 84:397-402.
12. Garvin AJ, Simon RM, Osborne CK, Merrill J, Young RC, Berard CW (1983) An autopsy study of histologic progression in non-Hodgkin's lymphoma: 192 cases from the National Cancer Center Institute. Cancer 52:393-398.
13. Gombart AF, Morosetti R, Miller CW, Sasid JW, Koeffler HP (1995) Detection of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. Blood 86:1534-1539.
14. INK4B, p53 and RB genes in primary lymphoid malignancies. Blood 87:4949-4958.
15. Hubbard SM, Chabner BA, DeVita VTJ, Simin R, Berard CW, Jones RB, Garvin AJ, Canellos GP, Osborne CK, Young RC (1982) Histologic progression in non-Hodgkin's lymphoma. Blood 59:258.
16. Johansson B, Mertens F, Mitelman F (1995) Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 86:3905-3914.
17. Kamb A, Gruis NA, Weaver FJ, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day R III, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
18. Koduru PRK, Zariwala M, Soni M, Gong JZ, Xiong Y, Broome JD (1995) Deletion of cyclin-dependent kinase-4 inhibitor genes p15 and p16 in non-Hodgkin's lymphoma. Blood 86:2900-2905.
19. Le Beau MM (1994) Cytogenetic analysis of hematological malignant diseases. In Barch MJ (ed): The ACT cytogenetics laboratory manual, New York: Raven Press, pp. 395-445.
20. Levine EG, Juneja S, Arthur D, Garson OM, Machnicki JL, Frizzera G, Ironside P, Cooper I, Hurd DD, Peterson BA, Mosel D, Bloomfield CD (1990) Sequential karyotypes in non-Hodgkin's lymphoma: Their nature and significance. Genes Chromosomes Cancer 1:270-280.
21. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R (1993) p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289-2295.
22. Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, Chaganti RSK, Dalla-Favera R (1994) Rearrangements of the BCL6 gene in diffuse large-cell non-Hodgkin's lymphoma. Blood 83:1757-1761.
23. Mitelman T (ed) (1995) An International System for Human Cytogenetic Nomenclature. Basel: S. Karger.
24. Moyzis RK, Albright KL, Bartholdi MF, Cram LS, Deaven LL, Hildebrand CE, Joste NE, Longmire JL, Meyne J, Schwarzacher-Robinson T (1987) Human chromosome-specific repetitive DNA sequences: Novel marker for genetic analysis. Chromosoma 95:375-386.
25. Musgrove EA, Lee CS, Buckley MF, Sutherland RL (1994) Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 91:8022-8026.
26. Nobori T, Mirua K, Wu D, Lois A, Takabayaski K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
27. Non-Hodgkin's lymphoma pathologic classification project (1982) National Cancer Institute-sponsored study of classification of non-Hodgkin's lymphoma: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2116.
28. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurowaka M, Tanaka T, Mitani K, Yazaki Y, Hirai H (1994) Homozygous loss of the cyclin-dependent kinase-4 inhibitor (p16) gene in human leukemias. Blood 84:2431-2445.
29. Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, Curcio-Brint AM, Liu Q, Pui C-H, Sherr CJ, Beach D, Look AT, Downing JR (1995) Frequent deletion of p16INK4a/ MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 85:2321-2330.
30. Olopade OI, Pomykala HM, Hagos F, Sveen LW, Espinosa R III, Dreyling MH, Gursky S, Stadler WM, Le Beau MM, Bohlander SK (1995) Construction of a 2.8-megabase YAC contig and cloning of the methyladenosine phosphorylase (MTAP) gene from the tumor suppressor region on 9p21. Proc Nat Acad Sci USA 92:6489-6493.
31. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P (1994) p16 homozygous deletions in acute lymplioblastic leukemia. Blood 85:657-663.
32. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 1993:1994-2004.
33. Schmidt EE, Ichimura K, Reifenberger G, Collins VP (1994) CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54:6321-6324.
34. Serrano M, Gomez-Lahoz F, DePinho RA, Beach D, Bar-Sagi D (1995) Inhibition of Ras-induced proliferation and cellular transformation bv p16INK4. Science 267:249-252.
35. Serrano M, Hannon GJ, Beach D (1995) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
36. Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, Rollins BJ (1995) Reciprocal RB inactivation and p16INK expression in primary lung cancers and cell lines. Cancer Res 55:505-509.
37. Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MAR, De Lord C, Clutterbuck RD, Treleaven JG, Powles RL, Nacheva F, Oscier DG, Karpas A, Lenoir GM, Smith SD, Millar JL, Catovsky D, Dyer MJS (1995) Deletions and rearrangements of CDKN2 in lymphoid malignancy. Blood 85:893-901.
38. Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 82:1140-1143.
39. Weaver-Feldhaus J, Gruis NA, Neuhausen S, Le Paslier D, Stockert E, Skolnick MH, Kamb A (1994) Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc Nat Acad Sci USA 91:7563-7567.
40. Weinberg RA (1991) Tumor suppressor genes. Science 254:1138-1146.